It is reported that aldose reductase inhibitor can promote G0/G1 cell cycle arrest of colon cancer cells by inhibiting PI3K/AKT/E2F1, and inhibit the proliferation and invasion by inhibiting PI3K/AKT/GSK3β 35, 36. This evidence concerns the gene AKR1B1 and malignant colon neoplasm.